Switching course, Gilead markets HIV drug for prevention
NEW YORK (Reuters) - Gilead Sciences Inc has begun marketing its HIV treatment Truvada in a way thousands of consumers already use it – to prevent infection with the virus that causes AIDS.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news